| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,105 | 1,585 | 10:16 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.07. | Bactiguard Holding AB: Bactiguard Holding AB's interim report second quarter 2026 | 229 | GlobeNewswire (Europe) | Solid performance driven by revenue growth
Second quarter 2026 (April - June)Total revenue amounted to SEK 57.1 (52.1) million, an increase of SEK 4.9 million corresponding to 9%.Net sales amounted... ► Artikel lesen | |
| BACTIGUARD Aktie jetzt für 0€ handeln | |||||
| 19.05. | Bactiguard Holding AB: Bulletin from Bactiguard Holding AB's (publ) Annual General Meeting | 222 | GlobeNewswire (Europe) | At Bactiguard Holding AB's (publ) Annual General Meeting (AGM) on 19 May 2026, the following resolutions were made:
The AGM adopted the income statements and balance sheets for 2025 and decided that... ► Artikel lesen | |
| 11.05. | Bactiguard Holding AB: Bactiguard and BD strengthen global partnership expanding access to Foley catheters designed to reduce infection risk for patients worldwide | 399 | GlobeNewswire (Europe) | Bactiguard Holding AB (publ) today announces an update to its long standing collaboration with license partner BD (Becton, Dickinson & Company), a leading global medical technology company, through... ► Artikel lesen | |
| 23.04. | Bactiguard Holding AB: Bactiguard Holding AB's interim report first quarter 2026 | 292 | GlobeNewswire (Europe) | Building momentum through partnerships, regulatory progress and organizational strength
First quarter 2026 (January - March)Total revenue amounted to SEK 46.9 (62.7) million, a decrease of SEK 15.8... ► Artikel lesen | |
| 05.02. | Bactiguard Holding AB: Bactiguard Holding AB's year-end report 2025 | 450 | GlobeNewswire (Europe) | A year of strategic execution concluded with a strong Q4
Fourth quarter 2025 (October - December)
Total revenue amounted to SEK 65.6 (68.3) million, a decrease of SEK 2.7 million corresponding to... ► Artikel lesen | |
| 19.12.25 | Bactiguard Holding AB: Bactiguard announces updated trauma license agreement with Zimmer Biomet | 445 | GlobeNewswire (Europe) | Bactiguard continues the collaboration with Zimmer Biomet in an updated agreement, giving Zimmer Biomet non-exclusive rights to continue to commercialize the ZNN Bactiguard coated trauma nail system... ► Artikel lesen | |
| 23.10.25 | Bactiguard Holding AB: Bactiguard Holding AB's interim report third quarter 2025 | 414 | GlobeNewswire (Europe) | Continued profitability and clinical evidence supporting future growth
Third quarter 2025 (July - September)
Total revenue amounted to SEK 48.4 (73.9) million, a decrease of SEK 25.5 million corresponding... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,512 | +0,66 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,069 | +1,46 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 43,295 | +0,35 % | dailyAktien: Boston Scientific - Langfristiges Stärkesignal | ||
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients | EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients
10.08.2026 / 09:00 CET/CEST
The... ► Artikel lesen | |
| PAUL HARTMANN | 201,00 | -0,50 % | Januar bis Juni 2026: PAUL HARTMANN steigert erneut Umsatz und Ergebnis | Heidenheim (ots) - - Erfolgreiches 1. Halbjahr: Umsatzerlöse steigen auf 1.252,0 Mio. EUR, organisches Umsatzwachstum von 3,3 %; bereinigtes EBITDA liegt mit 151,7 Mio. EUR um 25,9 Mio. EUR über Vorjahreswert-... ► Artikel lesen | |
| SYSMEX | 10,535 | +2,53 % | Sysmex Corporation Announces Increase In Q1 Profit | TOKYO (dpa-AFX) - Sysmex Corporation (SSMXY.PK) revealed a profit for its first quarter that Increased, from the same period last yearThe company's bottom line totaled JPY8.691 billion, or JPY14.17... ► Artikel lesen | |
| EMBECTA | 4,640 | +3,50 % | Embecta Corp.: embecta appoints Nimish Muzumdar as SVP and President, North America | PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical... ► Artikel lesen | |
| ADDLIFE | 14,410 | +0,21 % | AddLife AB: Interim Report January 1 - June 30, 2026 | Positive development across AddLife's companies"AddLife's companies are performing well across the board, with stronger margins, good growth and increased cash flow. Ourimprovement efforts are yielding... ► Artikel lesen | |
| ENOVIS | 23,000 | +2,68 % | Enovis Corporation: Enovis Announces Second Quarter 2026 Results | Second-quarter sales growth of 3% on a reported basis, 5% organicSecond-quarter Reconstructive sales grew 8% on a reported basis, 6% organicReaffirmed full-year 2026 guidance for revenue, adjusted... ► Artikel lesen | |
| COVETRUS | - | - | Laufende Fusionskontrollverfahren: Cencora Inc., Conshohocken, PA/USA (früher AmerisourceBergen); Erwerb eines Minderheitsanteils an Covetrus, Portland, ME/USA (weitere Aktionäre: Fonds von CD&R, Clayton, Dubilier, Rice, NY/USA, sowie von TPG Inc, Fort Wo | Datum der Anmeldung:04.05.2026Aktenzeichen:B3-61/26Unternehmen:Cencora Inc., Conshohocken, PA/USA (früher AmerisourceBergen); Erwerb eines Minderheitsanteils an Covetrus, Portland, ME/USA (weitere Aktionäre:... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,140 | -1,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 46,600 | +0,83 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen Euro | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,200 | +0,98 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| HEARTFLOW | 49,750 | 0,00 % | Heartflow Aktie auf Rekordhoch: Kurs steigt auf 48,7 USD | ||
| LIFESTANCE HEALTH GROUP | 12,470 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |